The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Amyloidosis-Associated Kidney Disease
Abstract
The amyloidoses are a group of disorders in which soluble proteins aggregate and deposit extracellularly in tissues as insoluble fibrils, causing progressive organ dysfunction. The kidney is one of the most frequent sites of amyloid deposition in AL, AA, and several of the hereditary amyloidoses. Amyloid fibril formation begins with the misfolding of an amyloidogenic precursor protein. The misfolded variants self-aggregate in a highly ordered manner, generating protofilaments that interact to form fibrils. The fibrils have a characteristic appearance by electron microscopy and generate birefringence under polarized light when stained with Congo red dye. Advances in elucidating the mechanisms of amyloid fibril formation, tissue deposition, and tissue injury have led to new and more aggressive treatment approaches for these disorders. This article reviews the pathogenesis, diagnosis, clinical manifestations, and treatment of the amyloidoses, focusing heavily on the renal aspects of each of these areas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Amyloidosis
Merlini, G., & Bellotti, V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023144 · Cited by 1,920
Prevalence of monoclonal gammopathy of undetermined significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Larson, D. R., Plevak, M. F., Offord, J. R., Dispenzieri, A., Katzmann, J. A., & Melton, L. J. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054494 · Cited by 1,423
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.
Kyle, R. A., & Ma, G. (1995) · PubMed · Cited by 1,255
Falk, R. H., Comenzo, R. L., & Skinner, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371306 · Cited by 1,180
Soto, C., Sigurdsson, E. M., Morelli, L., Asok Kumar, R., Castaño, E. M., & Frangione, B. (1998) · Nature Medicine · doi:10.1038/nm0798-822 · Cited by 876
Kyle, R. A., Gertz, M. A., Greipp, P. R., Witzig, T. E., Lust, J. A., Lacy, M. Q., & Therneau, T. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361702 · Cited by 688
Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis
Lachmann, H. J., Booth, D. R., Booth, S. E., Bybee, A., Gilbertson, J. A., Gillmore, J. D., Pepys, M. B., & Hawkins, P. N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013354 · Cited by 680
Skinner, M., Sanchorawala, V., Seldin, D. C., Dember, L. M., Falk, R. H., Berk, J. L., Anderson, J. J., O'Hara, C., Finn, K. T., Libbey, C. A., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-2-200401200-00008 · Cited by 618
Self-citationGillmore, J. D., Lovat, L. B., Persey, M. R., Pepys, M. B., & Hawkins, P. N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05252-1 · Cited by 595
Holmgren, G., Steen, L., Suhr, O., Ericzon, B.-G., Groth, C.-G., Andersen, O., Wallin, B. G., Seymour, A., Richardson, S., Hawkins, P. N., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)93127-m · Cited by 579
Variant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black Americans
Jacobson, D. R., Pastore, R. D., Yaghoubian, R., Kane, I., Gallo, G., Buck, F. S., & Buxbaum, J. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702133360703 · Cited by 554
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., Gallimore, J. R., Lovat, L. B., Bartfai, T., Alanine, A., Hertel, C., et al. (2002) · Nature · doi:10.1038/417254a · Cited by 540
Brenner, D. A., Jain, M., Pimentel, D. R., Wang, B., Connors, L. H., Skinner, M., Apstein, C. S., & Liao, R. (2004) · Circulation Research · doi:10.1161/01.res.0000126569.75419.74 · Cited by 450
Lachmann, H. J., Gallimore, R., Gillmore, J. D., Carr‐Smith, H. D., Bradwell, A. R., Pepys, M. B., & Hawkins, P. N. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04433.x · Cited by 435
Skinner, M., Anderson, J. J., Simms, R. W., Falk, R. H., Wang, M., Libbey, C. A., Jones, L. A., & Cohen, A. S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89487-9 · Cited by 370
Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., & Szarek, W. A. (1995) · Nature Medicine · doi:10.1038/nm0295-143 · Cited by 363
Autologous stem cell transplantation for primary systemic amyloidosis
Comenzo, R. L., & Gertz, M. A. (2002) · Blood · doi:10.1182/blood.v99.12.4276 · Cited by 357
Deposition of Transthyretin in Early Stages of Familial Amyloidotic Polyneuropathy
Mendes Sousa, M., Cardoso, I., Fernandes, R., Guimarães, A., & Saraiva, M. J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63050-7 · Cited by 344
Inhibiting transthyretin amyloid fibril formation via protein stabilization
Miroy, G. J., Lai, Z., Lashuel, H. A., Peterson, S. A., Strang, C., & Kelly, J. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15051 · Cited by 344
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis
Yan, S. D., Zhu, H., Zhu, A., Golabek, A., Du, H., Roher, A., Yu, J., Soto, C., Schmidt, A. M., Stern, D., et al. (2000) · Nature Medicine · doi:10.1038/76216 · Cited by 343
Westermark, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S., Frangione, B., Ikeda, S.-I., Masters, C. L., Merlini, G., Saraiva, M. J., & Sipe, J. D. (2005) · Amyloid · doi:10.1080/13506120500032196 · Cited by 341
Palladini, G., Lavatelli, F., Russo, P., Perlini, S., Perfetti, V., Bosoni, T., Obici, L., Bradwell, A. R., D'Eril, G. M., Fogari, R., et al. (2006) · Blood · doi:10.1182/blood-2005-11-4385 · Cited by 311
Comenzo, R. L., Zhang, Y., Martinez, C., Osman, K., & Herrera, G. A. (2001) · Blood · doi:10.1182/blood.v98.3.714 · Cited by 292
Clinical aspects of systemic amyloid diseases
Obici, L., Perfetti, V., Palladini, G., Moratti, R., & Merlini, G. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.08.014 · Cited by 278
Therapeutic strategies for human amyloid diseases
Sacchettini, J. C., & Kelly, J. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd769 · Cited by 261
Dispenzieri, A., Kyle, R. A., Lacy, M. Q., Therneau, T. M., Larson, D. R., Plevak, M. F., Rajkumar, S. V., Fonseca, R., Greipp, P. R., Witzig, T. E., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4192 · Cited by 239
Palladini, G., Perfetti, V., Perlini, S., Obici, L., Lavatelli, F., Caccialanza, R., Invernizzi, R., Comotti, B., & Merlini, G. (2005) · Blood · doi:10.1182/blood-2004-08-3231 · Cited by 227
Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits
Hrncic, R., Wall, J., Wolfenbarger, D. A., Murphy, C. L., Schell, M., Weiss, D. T., & Solomon, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64639-1 · Cited by 213
Sousa, M. M., Du Yan, S., Fernandes, R., Guimarães, A., Stern, D., & Saraiva, M. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07576.2001 · Cited by 212
Use of Abdominal Fat Tissue Aspirate in the Diagnosis of Systemic Amyloidosis
Libbey, C. A. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.143.8.1549 · Cited by 208
Miller, S. R., Sekijima, Y., & Kelly, J. W. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700059 · Cited by 198
Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's β-secretase
Scholefield, Z., Yates, E. A., Wayne, G., Amour, A., McDowell, W., & Turnbull, J. E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303059 · Cited by 182
Ancsin, J. B. (2003) · Amyloid · doi:10.3109/13506120309041728 · Cited by 171
Olofsson, B., Backman, C., Karp, K. H., & Suhr, O. B. (2002) · Transplantation · doi:10.1097/00007890-200203150-00015 · Cited by 169
Sanchorawala, V, Wright, D., Seldin, D., Dember, L., Finn, K., Falk, R., Berk, J., Quillen, K., & Skinner, M. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703200 · Cited by 168
Self-citationStem cell transplantation for the management of primary systemic amyloidosis
Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Gastineau, D. A., Chen, M. G., Ansell, S. M., Inwards, D. J., Micallef, I. N. M., Tefferi, A., & Litzow, M. R. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01208-1 · Cited by 160
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis
Hawkins, P. N. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200211000-00013 · Cited by 152
Seldin, D. C., Choufani, E. B., Dember, L. M., Wiesman, J. F., Berk, J. L., Falk, R. H., O’Hara, C., Fennessey, S. A., Finn, K. T., Wright, D. G., et al. (2003) · Clinical Lymphoma · doi:10.3816/clm.2003.n.005 · Cited by 145
Self-citationPoor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis
Dispenzieri, A. A., Lacy, M. Q., Rajkumar, S. V., Geyer, S. M., Witzig, T. E., Fonseca, R., Lust, J. A., Greipp, P. R., Kyle, R. A., & Gertz, M. A. (2003) · Amyloid · doi:10.3109/13506120309041743 · Cited by 140
Keeling, J., Teng, J., & Herrera, G. A. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700161 · Cited by 140
Gertz, M. A., Lacy, M. Q., Dispenzieri, A. A., Ansell, S. M., Elliott, M. A., Gastineau, D. A., Inwards, D. J., Micallef, I. N., Porrata, L. F., Tefferi, A., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704691 · Cited by 113
Liver transplantation in transthyretin-related familial amyloid polyneuropathy
Stangou, A. J., & Hawkins, P. N. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200410000-00012 · Cited by 110
Gregorini, G. A., Izzi, C., Obici, L. P., Tardanico, R., Röcken, C., Viola, B. F., Capistrano, M., Donadei, S., Biasi, L., Scalvini, T., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040382 · Cited by 97
Markowitz, G. S. (2004) · Advances in Anatomic Pathology · doi:10.1097/00125480-200401000-00005 · Cited by 95
Gillmore, J. D., Booth, D. R., Rela, M., Heaton, N. D., Rahman, V., Stangou, A. J., Pepys, M. B., & Hawkins, P. N. (2000) · QJM · doi:10.1093/qjmed/93.5.269 · Cited by 88
Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy.
Gervais, F., Chalifour, R. J., Garceau, D., Kong, X., Laurin, J., McLaughlin, R. W., Morissette, C., & Paquette, J. (2001) · PubMed · Cited by 83
Hawkins, P. N. (1994) · Clinical Science · doi:10.1042/cs0870289 · Cited by 83
Gillmore, J. D., Stangou, A. J., Tennent, G. A., Booth, D. R., Grady, J. O., Rela, M., Heaton, N. D., Wall, C. A. M., Keogh, J. A. B., & Hawkins, P. N. (2001) · Transplantation · doi:10.1097/00007890-200104150-00026 · Cited by 74
Inhibition of Amyloidosis Using Low-Molecular-Weight Heparins
Zhu, H., Yu, J., & Kindy, M. S. (2001) · Molecular Medicine · doi:10.1007/bf03401857 · Cited by 73
Ostertag revisited: The inherited systemic amyloidoses without neuropathy
Benson, M. D. (2005) · Amyloid · doi:10.1080/13506120500106925 · Cited by 73
Orthotopic liver transplantation for hereditary fibrinogen amyloidosis
Zeldenrust, S. R., Gertz, M. A., Uemichi, T., Björnsson, J., Wiesner, R. J., Schwab, T., & Benson, M. D. (2003) · Transplantation · doi:10.1097/01.tp.0000046526.10003.ec · Cited by 60
Familial nephropathic systemic amyloidosis caused by apolipoprotein Al variant Arg26
Vigushin, D. M., Gough, J., Allan, D. R., Alguacil, A., Penner, B., Pettigrew, N. M., Quinonez, G. E., Bernstein, K. N., Booth, S. E., Booth, D. R., et al. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068909 · Cited by 53
Renal amyloidosis in familial Mediterranean fever
Özen, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00485.x · Cited by 45
Emerging treatment approaches for the systemic amyloidoses
Dember, L. M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00535.x · Cited by 44
Self-citationMousson, C., Heyd, B., Justrabo, E., Rebibou, J.-M., Tanter, Y., Miguet, J., & Rifle, G. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01199.x · Cited by 36
Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy
Mpofu, S. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg101 · Cited by 28
Serum Amyloid A Peptide Interactions with Glycosaminoglycans: Evaluation by Affinity Chromatography
Ancsin, J. B., & Kisilevsky, R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-209-0:449 · Cited by 18
Cited by
Kittleson, M. M., Ruberg, F. L., Ambardekar, A. V., Brannagan, T. H., Cheng, R. K., Clarke, J. O., Dember, L. M., Frantz, J. G., Hershberger, R. E., Maurer, M. S., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.022 · Cited by 640
Self-citationEnhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity
Sorrentino, V., Romani, M., Mouchiroud, L., Beck, J. S., Zhang, H., D’Amico, D., Moullan, N., Potenza, F., Schmid, A. W., Rietsch, S., et al. (2017) · Nature · doi:10.1038/nature25143 · Cited by 630
Tirichen, H., Yaigoub, H., Xu, W., Wu, C., Li, R., & Li, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.627837 · Cited by 407
Metadata
- Authors
- Dember, L. M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-12
- Volume
- 17
- Issue
- 12
- Pages
- 3458-3471
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2122055094
- Cited by
- 409
- References
- 57
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.